Cognitive Behavior Therapy for Patients With Premature Ventricular Contractions - a Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Ventricular Premature Complexes
- Sponsor
- Karolinska Institutet
- Enrollment
- 19
- Locations
- 1
- Primary Endpoint
- Premature Ventricular Contractions effect on Quality-of-life (PVCEQT)
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of the present interdisciplinary research program is to develop and evaluate a disease-specific cognitive behavior therapy (CBT) protocol to increase quality of life (QoL) and reduce symptom burden in patients with Premature Ventricular Contractions (PVC).
Detailed Description
Patients will be recruited in collaboration with arrythmia specialist units in Stockholm and through advertisement in local newspapers and social media. All patients giving informed consent will be screened thoroughly by the research nurse and a psychologist before included by the study cardiologist. 20-30 patients that meet eligibility criteria will be included and receive 8-10 sessions of cognitive behavior therapy during 8-10 weeks. Due to the current Covid-19 pandemic, treatment will be delivered face-to face through a secure digital platform. The psychologist delivering the treatment will have direct access to the study cardiologist during treatment. Follow-up at 3 and 6 months.
Investigators
Frieder Braunschweig
Professor
Karolinska Institutet
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Premature Ventricular Contractions effect on Quality-of-life (PVCEQT)
Time Frame: 8 months from baseline
Version of the Atrial Fibrillation effects on Quality-of-life (AFEQT), adjusted to Premature Ventricular Contractions. Measures PVC-specific Quality of life in several domains. 14 questions graded on a 7 points likert scale. The total score ranges between 0 (severe symptoms and disability) and 98 (no symptoms and disability)
Secondary Outcomes
- Arrhythmia burden(8 months from baseline)
- Cardiac anxiety questionnaire (CAQ)(8 months from baseline)
- 12-Item Short-Form Health Survey (SF-12)(8 months from baseline)
- Symptom Checklist (SCL)(8 months from baseline)